Elevated plasma soluble LOX-1 level is the major modifiable risk factor for ischemic heart disease and could be considered as a suitable diagnostic biomarker for acute myocardial infarction patients but further larger clinical studies are required. The gene discussed is OLR1; the disease is acute myocardial infarction.